A drug utilisation study in patients treated with EXELON®/PROMETAX® (rivastigmine) transdermal patch

First published 24/09/2014

Last updated 02/07/2024

EU PAS number:

EUPAS7537

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

cena713d2409-redacted protocol

English (756.01 KB - PDF)View document

Updated protocol

ena713d2409-v02--protocol amendment redacted

First published: 22/02/2024

English (1.06 MB - PDF)View document

Study results

Study results

ena713d2409--legacy-clinical-study-report_Redacted2

English (6.45 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents